The need for safer medication use in pregnancy.
作者信息
Honein Margaret A, Gilboa Suzanne M, Broussard Cheryl S
机构信息
Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop E-86, Atlanta, GA 30333, USA
出版信息
Expert Rev Clin Pharmacol. 2013 Sep;6(5):453-5. doi: 10.1586/17512433.2013.827401. Epub 2013 Aug 24.
Abstract
摘要
相似文献
1
The need for safer medication use in pregnancy.孕期使用更安全药物的必要性。
Expert Rev Clin Pharmacol. 2013 Sep;6(5):453-5. doi: 10.1586/17512433.2013.827401. Epub 2013 Aug 24.
2
A to X: the problem of categorisation of drugs in pregnancy--an Australian perspective.从A到X：孕期用药的分类问题——澳大利亚视角
Med J Aust. 2011 Nov 21;195(10):572-4. doi: 10.5694/mja11.11119.
3
Drug therapy 101.药物治疗基础101。
Nursing. 2015 Jan;45(1):44-6. doi: 10.1097/01.NURSE.0000458920.95597.77.
4
Assessment of the Safety of Common Medications Used During Pregnancy.孕期常用药物安全性评估。
JAMA. 2021 Dec 21;326(23):2421-2422. doi: 10.1001/jama.2021.20191.
5
Safety profile of medication used during pregnancy: results of a multinational European study.孕期用药的安全性概况：一项欧洲多国研究的结果
Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):802-811. doi: 10.1002/pds.4213. Epub 2017 Apr 27.
6
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk.妊娠早期的药物：最常见的暴露及其对胎儿风险认识的关键差距。
Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):1013-8. doi: 10.1002/pds.3495. Epub 2013 Jul 29.
7
Consumer medication guides.
J Pain Palliat Care Pharmacother. 2010 Sep;24(3):298-301. doi: 10.3109/15360288.2010.503731.
8
Pharmacokinetic changes in the pregnant woman.孕妇的药代动力学变化。
J Perinat Neonatal Nurs. 2012 Jan-Mar;26(1):13-4. doi: 10.1097/JPN.0b013e318242fdf1.
9
Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.基于患者信息传单的孕妇和普通科医生对药物致畸风险的认知和使用信心。
Drug Saf. 2013 Jun;36(6):481-9. doi: 10.1007/s40264-013-0035-9.
10
A to X: the problem of categorisation of drugs in pregnancy - an Australian perspective. Comment.
Med J Aust. 2012 Feb 20;196(3):172; author reply 172-3. doi: 10.5694/mja11.11498.
引用本文的文献
1
Prevalence, predictors and pregnancy outcomes of unprescribed and herbal medicine use in Ibadan, Nigeria.尼日利亚伊巴丹市未处方和草药用药的流行情况、预测因素和妊娠结局。
BMC Complement Med Ther. 2023 Jan 20;23(1):17. doi: 10.1186/s12906-023-03838-8.
2
Delayed entry into prenatal care among women with pre-pregnancy health conditions, National Birth Defects Prevention Study, 1997-2011.有孕前健康状况的女性延迟产前护理的情况，全国出生缺陷预防研究，1997-2011 年。
Prev Med. 2022 Nov;164:107272. doi: 10.1016/j.ypmed.2022.107272. Epub 2022 Sep 21.
3
Medication use during pregnancy among women with congenital physical disabilities.先天性身体残疾女性在怀孕期间的用药情况。
Birth Defects Res. 2022 Aug 15;114(14):785-796. doi: 10.1002/bdr2.2048. Epub 2022 Jun 1.
4
Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis.埃塞俄比亚孕期处方药使用情况：一项系统评价与荟萃分析
SAGE Open Med. 2020 Jun 20;8:2050312120935471. doi: 10.1177/2050312120935471. eCollection 2020.
5
Obstetrician-Gynecologist Views of Pregnancy-Related Medication Safety.妇产科医生对与妊娠相关的药物安全性的看法。
J Womens Health (Larchmt). 2020 Aug;29(8):1113-1121. doi: 10.1089/jwh.2019.8007. Epub 2020 Apr 1.
6
[Pharmacokinetics and drug safety of oral infectious disease during pregnancy].[妊娠期口腔感染性疾病的药代动力学与药物安全性]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2018 Jun 1;36(3):319-324. doi: 10.7518/hxkq.2018.03.017.
7
Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009.美国育龄期孕妇和非孕妇的抑郁状况和治疗情况，2005-2009 年。
J Womens Health (Larchmt). 2012 Aug;21(8):830-6. doi: 10.1089/jwh.2011.3466. Epub 2012 Jun 12.
本文引用的文献
1
Risks of in utero exposure to valproate.子宫内接触丙戊酸盐的风险。
JAMA. 2013 Apr 24;309(16):1730-1. doi: 10.1001/jama.2013.4001.
2
Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.安全药物妊娠清单：基于网络信息的证据基础不足和指导意见不一致，2011 年。
Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):324-8. doi: 10.1002/pds.3410. Epub 2013 Jan 29.
3
Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009.美国育龄期孕妇和非孕妇的抑郁状况和治疗情况，2005-2009 年。
J Womens Health (Larchmt). 2012 Aug;21(8):830-6. doi: 10.1089/jwh.2011.3466. Epub 2012 Jun 12.
4
Unintended pregnancy in the United States: incidence and disparities, 2006.美国意外妊娠：发生率和差异，2006 年。
Contraception. 2011 Nov;84(5):478-85. doi: 10.1016/j.contraception.2011.07.013. Epub 2011 Aug 24.
5
Prescription drug use during pregnancy in developed countries: a systematic review.发达国家孕期处方药使用情况：系统评价。
Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):895-902. doi: 10.1002/pds.2184. Epub 2011 Jul 20.
6
Evolving knowledge of the teratogenicity of medications in human pregnancy.在人类妊娠中药物致畸性的知识不断发展。
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):175-82. doi: 10.1002/ajmg.c.30313. Epub 2011 Jul 15.
7
ACOG Committee Opinion No. 494: Sulfonamides, nitrofurantoin, and risk of birth defects.美国妇产科医师学会委员会意见第 494 号：磺胺类药物、呋喃妥因与出生缺陷风险。
Obstet Gynecol. 2011 Jun;117(6):1484-1485. doi: 10.1097/AOG.0b013e3182238c57.
8
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.孕期用药，特别关注处方药：1976-2008 年。
Am J Obstet Gynecol. 2011 Jul;205(1):51.e1-8. doi: 10.1016/j.ajog.2011.02.029. Epub 2011 Apr 22.
9
Health effects of prenatal radiation exposure.产前辐射暴露的健康影响。
Am Fam Physician. 2010 Sep 1;82(5):488-93.
10
Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.癫痫女性的管理问题——聚焦妊娠（循证综述）：II. 致畸作用与围产期结局：美国神经病学学会和美国癫痫协会质量标准小组委员会及治疗与技术小组委员会报告
Epilepsia. 2009 May;50(5):1237-46. doi: 10.1111/j.1528-1167.2009.02129.x.
Zotero 插件